Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.
- DOI
- 10.1007/s10147-025-02696-3
- Published
- 2025 Mar
- Container
- International journal of clinical oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10147-025-02696-3,
title = {Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.},
author = {Hotta K and Saeki S and Sakata S and Yamaguchi M and Harada D and Bessho A and Tanaka K and Inoue K and Inoue K and Gemba K and Kubo T and Sato A and Ichihara E and Watanabe H and Kishimoto J and Shioyama Y and Katsui K and Sugio K and Kiura K},
year = {2025},
journal = {International journal of clinical oncology},
doi = {10.1007/s10147-025-02696-3},
url = {https://doi.org/10.1007/s10147-025-02696-3}
}RIS
TY - JOUR TI - Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study. AU - Hotta K AU - Saeki S AU - Sakata S AU - Yamaguchi M AU - Harada D AU - Bessho A AU - Tanaka K AU - Inoue K AU - Inoue K AU - Gemba K AU - Kubo T AU - Sato A AU - Ichihara E AU - Watanabe H AU - Kishimoto J AU - Shioyama Y AU - Katsui K AU - Sugio K AU - Kiura K PY - 2025 JO - International journal of clinical oncology DO - 10.1007/s10147-025-02696-3 UR - https://doi.org/10.1007/s10147-025-02696-3 ER -
APA
K, H., S, S., S, S., M, Y., D, H., A, B., K, T., K, I., K, I., K, G., T, K., A, S., E, I., H, W., J, K., Y, S., K, K., K, S., & K, K. (2025). Five-year outcomes with gefitinib induction and chemoradiotherapy in EGFR-mutant stage III non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study.. International journal of clinical oncology. https://doi.org/10.1007/s10147-025-02696-3
Source records
- pubmed · retrieved 2026-09-26T22:07:42.644Z